|
Volumn 98, Issue 17, 2001, Pages 9836-9841
|
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
c
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 CHLOROPHENOTHIAZINE;
ACEPROMAZINE;
ACRIDINE DERIVATIVE;
CARBAMAZEPINE;
CHLORPROMAZINE;
CHLORPROTHIXENE;
CLOZAPINE;
HALOPERIDOL;
IMIPRAMINE;
MEPACRINE;
PHENAZINE;
PHENOTHIAZINE;
PHENOTHIAZINE DERIVATIVE;
PRION PROTEIN;
PROMAZINE;
PROMETHAZINE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BLOOD BRAIN BARRIER;
CONTROLLED STUDY;
CREUTZFELDT JAKOB DISEASE;
DOSE RESPONSE;
DRUG POTENCY;
DRUG STRUCTURE;
MOUSE;
NEUROBLASTOMA CELL;
NONHUMAN;
PRION DISEASE;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
WESTERN BLOTTING;
ACRIDINES;
ANIMALS;
CELLS, CULTURED;
CHLORPROMAZINE;
FATTY ACIDS;
HUMANS;
MICE;
NEUROBLASTOMA;
PHENOTHIAZINES;
PRION DISEASES;
PROTEIN CONFORMATION;
PRPSC PROTEINS;
QUINACRINE;
SAFETY;
STRUCTURE-ACTIVITY RELATIONSHIP;
TIME FACTORS;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0035859806
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.161274798 Document Type: Article |
Times cited : (620)
|
References (50)
|